• 2020 GAPNA Pharmacology Conference: Contemporary Pharmacology and Prescribing in Older AdultsJoin us at the 2020 GAPNA Pharmacology Conference:
    Contemporary Pharmacology and Prescribing in Older Adults

    April 14-18, 2020, Honolulu, HI.

    Earn up to 18 CNE hours.


    Find out more about it and REGISTER today!

  • W A N T E D   G A P N A   L E A D E R S!
    Call for Nominations!

    Have you ever considered stepping forward, accepting the challenge and volunteering for a position on the 2020-21 National Board of Directors? Register online NOW by March 22, 2020!

    Step Up - NOW is the Time! Register Here>

  • AwardNew for GAPNA members: MCM Education

    GAPNA has partnered with a MCM Education to offer an ongoing series of CNE programs available to GAPNA members. "Diagnosing and Managing Parkinson’s Disease in Older Adults," is the latest program offered.

    Parkinson’s disease (PD) is characterized by both motor and nonmotor symptoms. It is diagnosed based on the presence of two of four motor symptoms including rest tremor, bradykinesia, rigidity, and gait imbalance...

    Find out about it!

  • ConventionCALL FOR: Podium and Poster Abstracts

    For the 38th GAPNA Annual Conference
    at the Hyatt Regency
    New Orleans, LA, September 24-26, 2020

    GAPNA members are invited to submit an abstract about their innovative work, that should enrich the APRN's knowledge and/or enhance the care of an older adult. Deadline March 15, 2020.

    Find out more info and deadline dates

  • FREE CE for GAPNA MembersFREE continuing education credit is available for the following session:

    "Update in Chronic Kidney Disease Management and Prescribing"

    (session captured at the GAPNA 2018 Annual Conference)

    For January/February 2020 - Get Your Free CNE Now!

Risks High for Elderly Patients Receiving Angioplasty to Fix Narrowed Heart Artery

Elderly patients represent 72.6 percent of patients who receive the percutaneous coronary intervention treatment for unprotected left main coronary artery stenosis (ULMCA) stenosis.

Trend data, however, indicate the use of this procedure is slowly increasing, and is being used more often for lower-urgency procedures.

Poor health outcomes in elderly ULMCA patients are common and are likely influenced by both patient and procedural factors, including the type of stent used.

The study showed 40% of elderly patients die within the first 3 years of followup after the procedure.

Researchers concluded that clinical trials are needed to examine the safety and effectiveness of angioplasty in patients with ULMCA disease, with attention to best practices and the generalizability of trial populations.

More details are in Brennan et al. (2012). Characteristics and long-term outcomes of percutaneous revascularization of unprotected left main coronary artery stenosis in the United States. Journal of the American College of Cardiology, 59(7), 648-654.

Related Topic 1: 

GAPNA Newsletter Issue: